You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NHL

Showing 26 - 50 of 1,420
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
    • (no location specified)
    Sep 19, 2023

    B-cell Non Hodgkin Lymphoma Trial in Hanzhou (anti-CD19 CAR-NK)

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • anti-CD19 CAR-NK
    • Hanzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Jul 21, 2022

    Solid Tumors, NHL Trial in Canada, United States (KPT-9274, Niacin ER, Nivolumab)

    Terminated
    • Solid Tumors
    • NHL
    • Los Angeles, California
    • +7 more
    Jan 18, 2023

    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Chicago, Illinois
    • +2 more
    Aug 19, 2022

    CLL/SLL, NHL, MCL Trial in United States (HMPL-760)

    Recruiting
    • CLL/SLL
    • +8 more
    • Atlanta, Georgia
    • +3 more
    Feb 24, 2022

    Follicular Lymphoma (FL/Indolent NHL), Aggressive NHL (a NHL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma

    Completed
    Has Results
    • Follicular Lymphoma (FL/Indolent NHL)
    • +4 more
    • Huntsville, Alabama
    • +22 more
    Apr 1, 2022

    B-cell Non-Hodgkin's Lymphoma Trial in Cincinnati (IMM0306)

    Recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • Cincinnati, Ohio
      The Christ Hospital
    Apr 1, 2022

    Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

    Not yet recruiting
    • Advanced Malignancies
    • 1A46 Drug Substance
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Aug 4, 2023

    Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial in Miami (Mosunetuzumab,

    Not yet recruiting
    • Refractory Non-Hodgkin Lymphoma
    • +2 more
    • Miami, Florida
      University of Miami
    Aug 3, 2022

    Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • Perth, Western Australia, Australia
      Linear Clinical Research Ltd
    Apr 20, 2023

    Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL Trial in United States (KT-413)

    Recruiting
    • Non Hodgkin Lymphoma
    • +3 more
    • Washington, District of Columbia
    • +5 more
    Nov 29, 2022

    Non-Hodgkin Lymphoma Trial in Santa Monica, Pittsburgh (IGN002)

    Terminated
    • Non-Hodgkin Lymphoma
    • IGN002
    • Santa Monica, California
    • +1 more
    Feb 23, 2022

    Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma Trial in China (Relmacabtagene

    Not yet recruiting
    • Lymphoma, Large B-Cell, Diffuse
    • +3 more
    • Relmacabtagene Autoleucel
    • +2 more
    • Guangzhou, Guangdong, China
    • +12 more
    Oct 24, 2023

    Hematoma Trial in Beijing (CM355)

    Active, not recruiting
    • Hematoma
    • Beijing, China
      Beijing university cancer hospital
    Jan 10, 2022

    Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma, Relapsed
    • +8 more
    • PBCAR20A
    • +2 more
    • Duarte, California
    • +4 more
    Jan 4, 2023

    Non-hodgkin's Lymphoma Trial in Beijing (GNC-038)

    Recruiting
    • Non-hodgkin's Lymphoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Jan 12, 2023

    Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

    Recruiting
    • Non-Hodgkin Lymphoma
    • Hodgkin Lymphoma
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Jan 25, 2023

    Non-Hodgkin's Lymphoma Trial in Hangzhou (ThisCART19A)

    Recruiting
    • Non-Hodgkin's Lymphoma
    • ThisCART19A
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Apr 21, 2022

    Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

    Not yet recruiting
    • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
    • (no location specified)
    Mar 23, 2023

    Non Hodgkin's Lymphoma Trial in Beijing (Allogenic CD19-CAR-?dT cell, Fludarabine, Cyclophosphamide)

    Recruiting
    • Non Hodgkin's Lymphoma
    • Allogenic CD19-CAR-γδT cell
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Jan 31, 2023

    Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in Worldwide (JBH492)

    Recruiting
    • Non-Hodgkins Lymphoma
    • Chronic Lymphocytic Leukemia
    • Phoenix, Arizona
    • +10 more
    Nov 11, 2022

    Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in Changsha, Suzhou (U16)

    Recruiting
    • Relapsed or Refractory Non-Hodgkin's Lymphoma
    • Changsha, Hunan, China
    • +1 more
    Mar 13, 2023

    Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

    Recruiting
    • Follicular Lymphoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Lymphoma, Non-Hodgkin Trial in China (DZD8586)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Beijing, Beijing, China
    • +5 more
    Apr 25, 2023

    Non-Hodgkin Lymphoma Trial in Milano (Romiplostim)

    Completed
    • Non-Hodgkin Lymphoma
    • Milano, Italy
      Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
    Aug 10, 2022